Stericycle (SRCL) Tops Q2 EPS by 2c, Beats on Revenues
Get Alerts SRCL Hot Sheet
Price: $46.51 -6.74%
Revenue Growth %: -2.8%
Financial Fact:
Less: Net Income Attributable to Noncontrolling Interests: 378K
Today's EPS Names:
FRSB, DGICA, UXIN, More
Revenue Growth %: -2.8%
Financial Fact:
Less: Net Income Attributable to Noncontrolling Interests: 378K
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Stericycle (NASDAQ: SRCL) reported Q2 EPS of $1.15, $0.02 better than the analyst estimate of $1.13. Revenue for the quarter came in at $917.7 million versus the consensus estimate of $903.79 million.
SECOND QUARTER HIGHLIGHTS COMPARED TO PRIOR YEAR:
- Revenues of $917.7 million, an increase of 2.9%, including a 1.3% unfavorable impact from foreign exchange
- Gross profit of $381.8 million, an increase of 1.1%
- Reached proposed settlement of class action lawsuit of $295.0 million to reduce uncertainty and expense of continued litigation
- Loss per share of $1.74, due primarily to the impact of the proposed class action settlement, and Adjusted earnings per share (“Adjusted EPS”) of $1.15
For earnings history and earnings-related data on Stericycle (SRCL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Data I/o Corp (DAIO) Misses Q2 EPS by 7c
- Minerals Technologies (MTX) Tops Q1 EPS by 16c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!